InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-7.8%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Rothman Joel, Directeur du Développement. Director active across 1 company, notably Equillium, Inc.. Cumulatively, 6 disclosures have been recorded. Activity tracked since 10 June 2021. The latest transaction was disclosed on 9 June 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
15,000 shares@ US$0.5614.4% of flowCommon StockSEC:0001209191-24-000518:0
6,244 shares@ US$1.8520.2% of flowCommon StockSEC:0001209191-23-001366:0
1,290 shares@ US$2.350.0019% mcap7.6% of flowCommon StockSEC:0001209191-21-069176:0
1,290 shares@ US$2.355.0% of flowCommon StockSEC:0001209191-21-069176
7,742 shares@ US$2.3527.7% of flowCommon stock, par value $0.0001 per shareSEC:0001209191-21-040313
7,742 shares@ US$2.350.011% mcap42.4% of flowCommon stock, par value $0.0001 per shareSEC:0001209191-21-040313:0
6 of 6 declarations
About Rothman Joel
Joel Rothman is Chief Development Officer at Equillium, Inc. He is responsible for business development strategy and innovation within the company. His role is essential in identifying new growth opportunities and leading strategic initiatives.
